BPG is committed to discovery and dissemination of knowledge
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Asami K, Atagi S. Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer. World J Clin Oncol 2014; 5(4): 646-659 [PMID: 25302168 DOI: 10.5306/wjco.v5.i4.646]
Corresponding Author of This Article
Kazuhiro Asami, MD, Department of Clinical Oncology, National Hospital Organization Kinki-chuo Chest Medical Center, 1180 Nagasone-cho Kita-ku, Sakai City, Osaka 591-8555, Japan. kazu.taizo@nifty.com
Research Domain of This Article
Oncology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9202)
All Articles published online
|
Publishing Process of This Article
|
Oct 10, 2014 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Total Visits of This Article
2018 | Number of total visits
Rank | Countries/Territories | Count | Percent |
1 | Japan | 1 | 100% |